Wednesday, February 11, 2015 11:06:55 AM
A couple of personal observations about life on a MB. All's well when the share price is rising. Then the company is pretty much doing things right, in the highly rational minds of the MB denizens, at least. When the pps is not up to expectations (and we each have our own) then the management is stupid, duplicitous and incompetent. How do we know that they are? All you have to do is look to see that they aren't performing according to the carefully imagined timeline that we have, or they haven't met the pre-imagined benchmark. In those cases, if the unhappy shareholders weren't manacled at gunpoint to this investment, they would surely get out. Because, at their own admission, there are numerous companies that are better investments than the one they are posting about. But, alas, they have no choice but to stick it out until they make their x000% expected profit.
I'm not saying that any of us is above feeling various emotions about our money and where it's invested. But, people need to recognize the rules of engagement before going into any investment, particularly a small-cap bio with no approved product and no income. The reason it's called a speculative investment is because there is absolutely no guarantee of return. I believe NW has sound science, honest and capable management, and a better than 50% chance at success. That's why I've been here for over 4 years. I am not all-in, nor will I ever be. I invest only what I can afford to lose without substantial hardship. And, no matter how promising news might look in the future, I will stick by my rule. I've invested in biotechs since the 80's when monoclonal antibodies were about to change the world as we knew it. It's been a learning experience. "To everything there is a season, and a time to every purpose under heaven." Sage investing advice, IMO. Watch the 'seasons' and act accordingly. GLTA
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM